News

It is with great pleasure that we announce the appointment of Amanda Selvaratnam as the new Chair of the PraxisAuril Board, taking over from Iain Thomas. Amanda's extensive experience in technology transfer and innovation makes her a valuable addition to our team.

PraxisAuril’s former CEO, Maxine Purdie (Ficarra) has been made an MBE in the New Year’s Honours list for her contribution to knowledge exchange. Maxine led the UK’s national association for KE for 20 years before stepping down in September 2022. 

Research England has released an independent review undertaken by Canadian consultants McIvorStones that explores opportunities and challenges for scale-up and launch of digital spinouts across England’s HE landscape, including those with low spinout rates from traditional STEM and life-science disciplines.

KEF3 outcomes have been published by Research England, updating each HEP’s KEF profile in the context of a cluster peer group.

PraxisAuril aids launch of the KE Concordat repository

PraxisAuril is thrilled to announce the launch of a new Community of Practice (CoP) focused on the field of social venture building and self-sustaining commercialisation in Arts, Humanities, and Social Science (AHSS) research.

Trials to lower brain pressure in patients with type2 diabetes also reduced the number of 'blinding' headaches

Proximity to Newcastle University and National Innovation Centre for Data key to Leonardo announcement .

PraxisAuril is delighted to announce the appointment of David Russell as its new CEO.

University of Birmingham spinout ChromaTwist Ltd has secured £487k of equity investment to develop its new class of fluorescent dyes for the flow cytometry reagent market.

PraxisAuril is delighted to share the release of a new technical report from the University Commercialisation and Innovation Policy Evidence Unit (UCI) headed up by Tomas Coates Ulrichsen and based at the University of Cambridge. The report marks a significant step forward in our shared understanding of current practice in taking equity in university spinouts in the UK. Thank you to all the PraxisAuril members who took the time to speak to the UCI team about your spinout policies, typical practice and experience with the wide variety of stakeholders involved.  

Researchers from the University of Birmingham are developing a rapid test for gum disease and expect the technology to play a pivotal role in early detection of heart or lung disease, type 2 diabetes and rheumatoid arthritis.

Research England’s second iteration of new and enhanced KEF dashboards released and passes another major milestone as it builds on positive feedback on the first version.

IN-PART campaign surfaces over 100 next-generation solutions to the water pollution crisis from academia

A unique testing method invented at the University of Birmingham (UK) is set for a global rollout after its commercial rights were exclusively licensed to the world’s largest COVID-19 test provider, Innova Medical Group, Inc.